SCHEMBL5650722

SCHEMBL5650722

COc1ccc(CNc2cc(OC)c(Cl)cc2OC)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
CRHBP P24387 1/20 0.58
CRHR2 Q13324 1/20 0.58
ALDH1A1 P00352 3/20 0.50
GAA P10253 2/20 0.50
KDM4E B2RXH2 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
TUBB4A P04350 1/20 0.50
TUBB P07437 1/20 0.50
TUBA3C P0DPH7 1/20 0.50
TUBA1B P68363 1/20 0.50
TUBA4A P68366 1/20 0.50
TUBB4B P68371 1/20 0.50
TUBB3 Q13509 1/20 0.50
TUBB2A Q13885 1/20 0.50
TUBB8 Q3ZCM7 1/20 0.50
TUBA3E Q6PEY2 1/20 0.50
TUBA1A Q71U36 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL597148 0.81 MAPT (0.61) MAPTMEN1KMT2ACRHBPCRHR2
SCHEMBL5436695 0.76 POLB (0.55) MAPTMEN1KMT2AGAAKDM4E
SCHEMBL5522100 0.76 MAPT (0.51) MAPTMEN1KMT2ACRHBPCRHR2
SCHEMBL29198576 0.75 PGK1 (0.56) MAPTMEN1KMT2AALDH1A1GAA
SCHEMBL11036299 0.74 MAPT (0.53) MAPTMEN1KMT2AALDH1A1GAA
SCHEMBL20976100 0.74 HTR2A (0.72) ALDH1A1GAAKDM4ESMN1; SMN2
SCHEMBL29633061 0.74 HTR2A (0.72) ALDH1A1GAAKDM4ESMN1; SMN2
SCHEMBL6816299 0.74 MAPT (0.51) MAPTMEN1KMT2ACRHBPCRHR2
SCHEMBL5521162 0.73 MAPT (0.81) MAPTMEN1KMT2ACRHBPCRHR2
SCHEMBL9190510 0.73 TUBB4A (0.77) MAPTMEN1KMT2AALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299092-A1 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors WYETH (US) 2007-12-27 US disclosed
WO-2005115145-A2 QUINONE SUBSTITUTED QUINAZOLINE AND QUINOLINE KINASE INHIBITORS WYETH (US) 2005-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299092-A1 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors KDR, FLT1, FLT4 MAPT 3931/4885MEN1 3702/4885KMT2A 2134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.